GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ModivCare Inc (NAS:MODV) » Definitions » Return-on-Tangible-Equity

ModivCare (ModivCare) Return-on-Tangible-Equity : 0.00% (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is ModivCare Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. ModivCare's annualized net income for the quarter that ended in Mar. 2024 was $-89 Mil. ModivCare's average shareholder tangible equity for the quarter that ended in Mar. 2024 was $-991 Mil. Therefore, ModivCare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was N/A%.

The historical rank and industry rank for ModivCare's Return-on-Tangible-Equity or its related term are showing as below:

During the past 13 years, ModivCare's highest Return-on-Tangible-Equity was 48.70%. The lowest was -7.12%. And the median was 10.57%.

MODV's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 9.91
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

ModivCare Return-on-Tangible-Equity Historical Data

The historical data trend for ModivCare's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ModivCare Return-on-Tangible-Equity Chart

ModivCare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 Negative Tangible Equity - - -

ModivCare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ModivCare's Return-on-Tangible-Equity

For the Medical Care Facilities subindustry, ModivCare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ModivCare's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ModivCare's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where ModivCare's Return-on-Tangible-Equity falls into.



ModivCare Return-on-Tangible-Equity Calculation

ModivCare's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-204.46/( (-1053.507+-990.294 )/ 2 )
=-204.46/-1021.9005
=N/A %

ModivCare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-89.2/( (-990.294+-990.791)/ 2 )
=-89.2/-990.5425
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


ModivCare  (NAS:MODV) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


ModivCare Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of ModivCare's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


ModivCare (ModivCare) Business Description

Traded in Other Exchanges
Address
6900 Layton Avenue, 12th Floor, Denver, CO, USA, 80237
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
Executives
Barbara Gutierrez officer: Chief Financial Officer 8950 E. LOWRY BLVD., DENVER CO 80230
L Heath Sampson officer: Chief Financial Officer C/O ADVANCED EMISSIONS SOLUTIONS, INC., 9135 S RIDGELINE BLVD STE 200, HIGHLANDS RANCH CO 80129
Coliseum Capital Management, Llc director, 10 percent owner 105 ROWAYTON AVENUE, ROWAYTON CT 06853
Henry Toledo officer: Chief People Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Jessica Kral officer: Chief Information Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Anne E, Bailey officer: President, Home Division 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Rebecca Orcutt officer: VP, Chief Accounting Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Brett M. Hickman officer: Chief Commercial Officer 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Ilias Simpson officer: President, Transportation 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Jason E Anderson officer: President of ModivCare Home 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Grover Wray officer: Chief Human Resources Officer DIGITALGLOBE, INC., 1300 WEST 120TH AVENUE, WESTMINSTER CO 80234
Daniel E Greenleaf director, officer: CEO and President C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Jonathan B Bush officer: SVP, GC and Secretary 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Kenneth Shepard officer: Vice President, CAO 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Stacy Saal director 4700 SOUTH SYRACUSE STREET, 4TH FLOOR, DENVER CO 80237